MucoLife Therapeutics, an alumnus of the Health Wildcatters accelerator, develops patented, innovative mucus-dissolving therapies specifically targeting pulmonary mucus obstruction. In response to ...
People with CF may undergo multiple medical procedures to manage lung infections, digestive issues, and other complications. Cystic fibrosis (CF) is a genetic condition that leads to the production of ...
The cost of medication was too high for thousands of CF sufferers around the world. Now a Bangladeshi company is making a generic version that will change lives ...
After only 28 days of treatment with ARCT-032 (10 mg), 4 out of 6 Class I CF participants exhibited encouraging reduction of mucus plug number and mucus volume 12-week study enrolling up to 20 CF ...
Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, ...
Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...
The Minnesota Cystic Fibrosis Center recently gained membership to a research network for the disease, creating greater opportunities to treat patients in the Midwest and across the nation. The center ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback